heptanol has been researched along with Coronary Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| CULTRERA, G; SANSON, A; VINCENZI, M | 1 |
| DILORENZO, S; IACCARINO, P | 1 |
| Barrabés, JA; Garcia-Dorado, D; González, MA; Inserte, J; Juliá, M; Ruiz-Meana, M; Solares, J; Soler-Soler, J | 1 |
3 other study(ies) available for heptanol and Coronary Disease
| Article | Year |
|---|---|
[The use of 2-amino-6-methyl-6-heptanol hydrochloride in coronary insufficiency].
Topics: Amino Alcohols; Coronary Artery Disease; Coronary Disease; Heart Defects, Congenital; Heart Valves; Heptanol; Humans | 1963 |
[THE INDICATIONS OF 2-AMINO-6-METHYL-6-HEPTANOL HYDROCHLORIDE IN THE THERAPY OF HEART DISEASES].
Topics: Amino Alcohols; Arrhythmias, Cardiac; Coronary Disease; Heart Diseases; Heart Failure; Heptanol; Humans; Pulmonary Heart Disease | 1964 |
Gap junction uncoupler heptanol prevents cell-to-cell progression of hypercontracture and limits necrosis during myocardial reperfusion.
Topics: Animals; Cell Separation; Coronary Circulation; Coronary Disease; Disease Progression; Gap Junctions; Heart; Hemodynamics; Heptanol; Hypoxia; In Vitro Techniques; Myocardial Contraction; Myocardial Reperfusion Injury; Myocardium; Necrosis; Rats; Rats, Sprague-Dawley; Uncoupling Agents | 1997 |